Enhancing Stability

There are many factors which effect drug stability (e.g. temperature, light, pH, oxidation etc.) and both chemical and physical stability are vital to ensuring that therapeutics can be manufactured, stored, transported and administered to patients without a loss of efficacy or safety.

Some pharmaceutical processing technologies expose drug substances to damaging environments, such as high temperatures, mechanical stress and shear forces, which can lead to chemical and physical degradation, and leave them susceptible to further instability.

Crystec’s mSAS® supercritical fluid (SCF) technology can be applied to a range of approaches to provide enhanced stability for small and large molecule therapeutics.

 
  • Highly crystalline material

  • Low amorphous content

  • Eliminate residual solvent and impurities

  • Particles coated to protect against moisture

  • Ambient biotherapeutics

 Find Out More

 
mSAS® Case Study: Biomolecule Processing

mSAS® Case Study: Biomolecule Processing

mSAS® Case Study: Natural Products

mSAS® Case Study: Natural Products

 
mSAS® Strategies for Enhancing Stability

mSAS® Strategies for Enhancing Stability